Advertisement
Review Article| Volume 38, ISSUE 4, P669-677, December 2018

Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rive C.M.
        • Bourke J.
        • Phillips E.J.
        Testing for drug hypersensitivity syndromes.
        Clin Biochem Rev. 2013; 34: 15-38
        • Bharadwaj M.
        • Illing P.
        • Theodossis A.
        • et al.
        Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
        Annu Rev Pharmacol Toxicol. 2011; https://doi.org/10.1146/annurev-pharmtox-010611-134701
        • White K.D.
        • Chung W.H.
        • Hung S.I.
        • et al.
        Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response.
        J Allergy Clin Immunol. 2015; 136 ([quiz: 235]): 219-234
        • Pavlos R.
        • Mallal S.
        • Ostrov D.
        • et al.
        T cell-mediated hypersensitivity reactions to drugs.
        Annu Rev Med. 2015; 66: 439-454
        • Mallal S.
        • Nolan D.
        • Witt C.
        • et al.
        Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
        Lancet. 2002; 359: 727-732
        • Hetherington S.
        • Hughes A.R.
        • Mosteller M.
        • et al.
        Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
        Lancet. 2002; 359: 1121-1122
        • Chung W.H.
        • Hung S.I.
        • Hong H.S.
        • et al.
        Medical genetics: a marker for stevens-johnson syndrome.
        Nature. 2004; 428: 486
        • Man C.B.
        • Kwan P.
        • Baum L.
        • et al.
        Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese.
        Epilepsia. 2007; 48: 1015-1018
        • Hung S.I.
        • Chung W.H.
        • Liou L.B.
        • et al.
        HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
        Proc Natl Acad Sci U S A. 2005; 102: 4134-4139
        • Zhang F.R.
        • Liu H.
        • Irwanto A.
        • et al.
        HLA-B*13:01 and the dapsone hypersensitivity syndrome.
        N Engl J Med. 2013; 369: 1620-1628
        • Faulkner L.
        • Meng X.
        • Park B.K.
        • et al.
        The importance of hapten-protein complex formation in the development of drug allergy.
        Curr Opin Allergy Clin Immunol. 2014; 14: 293-300
        • Pichler W.J.
        The p-i concept: pharmacological interaction of drugs with immune receptors.
        World Allergy Organ J. 2008; 1: 96-102
        • Illing P.T.
        • Vivian J.P.
        • Dudek N.L.
        • et al.
        Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
        Nature. 2012; 486: 554-558
        • Norcross M.A.
        • Luo S.
        • Lu L.
        • et al.
        Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.
        AIDS. 2012; https://doi.org/10.1097/QAD.0b013e328355fe8f
        • Ostrov D.A.
        • Grant B.J.
        • Pompeu Y.A.
        • et al.
        Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
        Proc Natl Acad Sci U S A. 2012; https://doi.org/10.1073/pnas.1207934109
        • Yerly D.
        • Pompeu Y.A.
        • Schutte R.J.
        • et al.
        Structural elements recognized by abacavir-induced T cells.
        Int J Mol Sci. 2017; 18 ([pii:E1464])
        • Mallal S.
        • Phillips E.
        • Carosi G.
        • et al.
        HLA-B*5701 screening for hypersensitivity to abacavir.
        N Engl J Med. 2008; 358: 568-579
        • Phillips E.J.
        • Chung W.H.
        • Mockenhaupt M.
        • et al.
        Drug hypersensitivity: pharmacogenetics and clinical syndromes.
        J Allergy Clin Immunol. 2011; 127: S60-S66
        • White K.D.
        • Abe R.
        • Ardern-Jones M.
        • et al.
        SJS/TEN 2017: building multidisciplinary networks to drive science and translation.
        J Allergy Clin Immunol Pract. 2018; 6: 38-69
        • Denisov I.G.
        • Grinkova Y.V.
        • Baylon J.L.
        • et al.
        Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
        Biochemistry. 2015; https://doi.org/10.1021/acs.biochem.5b00079
        • Ota T.
        • Kamada Y.
        • Hayashida M.
        • et al.
        Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.
        Int J Med Sci. 2015; 12: 78-82
        • Ogese M.O.
        • Jenkins R.E.
        • Maggs J.L.
        • et al.
        Characterization of peroxidases expressed in human antigen presenting cells and analysis of the covalent binding of nitroso sulfamethoxazole to myeloperoxidase.
        Chem Res Toxicol. 2015; https://doi.org/10.1021/tx500458k
        • Lu S.C.
        Glutathione synthesis.
        Biochim Biophys Acta. 2013; 1830: 3143-3153
        • Tang W.
        • Jiang Y.F.
        • Ponnusamy M.
        • et al.
        Role of Nrf2 in chronic liver disease.
        World J Gastroenterol. 2014; 20: 13079-13087
        • Oetjens M.T.
        • Denny J.C.
        • Ritchie M.D.
        • et al.
        Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.
        Pharmacogenomics. 2013; 14: 735-744
        • Selvaraj S.
        • Schmitt A.D.
        • Dixon J.R.
        • et al.
        Complete haplotype phasing of the MHC and KIR loci with targeted HaploSeq.
        BMC Genomics. 2015; 16: 900
        • Rajagopalan S.
        • Long E.O.
        Understanding how combinations of HLA and KIR genes influence disease.
        J Exp Med. 2005; 201: 1025-1029
        • Parkes M.
        • Cortes A.
        • van Heel D.A.
        • et al.
        Genetic insights into common pathways and complex relationships among immune-mediated diseases.
        Nat Rev Genet. 2013; 14: 661-673
        • Shiohara T.
        • Kano Y.
        A complex interaction between drug allergy and viral infection.
        Clin Rev Allergy Immunol. 2007; 33: 124-133
        • Smith K.J.
        • Skelton H.G.
        • Yeager J.
        • et al.
        Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. the military medical consortium for the advancement of retroviral research (MMCARR).
        Clin Exp Dermatol. 1997; 22: 118-123
        • Aihara Y.
        • Ito S.I.
        • Kobayashi Y.
        • et al.
        Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction.
        Br J Dermatol. 2003; 149: 165-169
        • Eliaszewicz M.
        • Flahault A.
        • Roujeau J.C.
        • et al.
        Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.
        J Am Acad Dermatol. 2002; 47: 40-46
        • Stricker D.
        BrightStat.com: free statistics online.
        Comput Methods Programs Biomed. 2008; 92: 135-143
        • Dalbeth N.
        • Stamp L.K.
        • Merriman T.R.
        The genetics of gout: towards personalised medicine?.
        BMC Med. 2017; 15: 108
        • Ashley E.A.
        • Butte A.J.
        • Wheeler M.T.
        • et al.
        Clinical assessment incorporating a personal genome.
        Lancet. 2010; 375: 1525-1535